当前蛋白身份:Q91MA7 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
3SDY Crystal Structure of Broadly Neutralizing Antibody CR8020 Bound to the Influenza A H3 Hemagglutinin 提交 2011-06-09 Assembly 1 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 27–345(319 aa) 片段:UNP residues 27-345
链 B 346–521(176 aa) 片段:UNP residues 346-521
未记录 SO4 SULFATE ION × 30 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.4;298 K;1.8M ammonium sulfate, 100mM sodium acetate 5.4, and 50mM NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 298K
分辨率 2.85 Å R-free 0.235
4FNK Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin 提交 2012-06-19 Assembly 1 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa) 片段:UNP residues 27-345
链 B 346–519(174 aa) 片段:UNP residues 346-519
链 C 27–345(319 aa) 片段:UNP residues 27-345
链 D 346–519(174 aa) 片段:UNP residues 346-519
链 E 27–345(319 aa) 片段:UNP residues 27-345
链 F 346–519(174 aa) 片段:UNP residues 346-519
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 SO4 SULFATE ION × 6 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;2.0 M ammonium sulfate, 100 mM sodium cacodylate, pH 6.5, 200 mM sodium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 1.90 Å R-free 0.189
4FP8 Crystal structure of broadly neutralizing antibody C05 bound to H3 influenza hemagglutinin, HA1 subunit 提交 2012-06-21 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 59–325(267 aa) 片段:UNP residues 59-325
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.5;277 K;10% w/v PEG3000, 200 mM zinc acetate, 100 mM sodium acetate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.95 Å R-free 0.241
4FP8 Crystal structure of broadly neutralizing antibody C05 bound to H3 influenza hemagglutinin, HA1 subunit 提交 2012-06-21 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 B 59–325(267 aa) 片段:UNP residues 59-325
未记录 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.5;277 K;10% w/v PEG3000, 200 mM zinc acetate, 100 mM sodium acetate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.95 Å R-free 0.241
4FP8 Crystal structure of broadly neutralizing antibody C05 bound to H3 influenza hemagglutinin, HA1 subunit 提交 2012-06-21 Assembly 3 其他组合 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 59–325(267 aa) 片段:UNP residues 59-325
未记录 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.5;277 K;10% w/v PEG3000, 200 mM zinc acetate, 100 mM sodium acetate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.95 Å R-free 0.241
4FP8 Crystal structure of broadly neutralizing antibody C05 bound to H3 influenza hemagglutinin, HA1 subunit 提交 2012-06-21 Assembly 4 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 D 59–325(267 aa) 片段:UNP residues 59-325
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.5;277 K;10% w/v PEG3000, 200 mM zinc acetate, 100 mM sodium acetate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.95 Å R-free 0.241
4FQR Crystal structure of broadly neutralizing antibody C05 bound to H3 influenza hemagglutinin 提交 2012-06-25 Assembly 1 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 27–345(319 aa) 片段:UNP residues 27-345
链 B 346–519(174 aa) 片段:UNP residues 346-519
链 C 27–345(319 aa) 片段:UNP residues 27-345
链 D 346–519(174 aa) 片段:UNP residues 346-519
链 E 27–345(319 aa) 片段:UNP residues 27-345
链 F 346–519(174 aa) 片段:UNP residues 346-519
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;28% w/v PEG400, 200 mM calcium chloride, 100 mM HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 4.10 Å R-free 0.334
4FQR Crystal structure of broadly neutralizing antibody C05 bound to H3 influenza hemagglutinin 提交 2012-06-25 Assembly 2 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 G 27–345(319 aa) 片段:UNP residues 27-345
链 H 346–519(174 aa) 片段:UNP residues 346-519
链 I 27–345(319 aa) 片段:UNP residues 27-345
链 J 346–519(174 aa) 片段:UNP residues 346-519
链 K 27–345(319 aa) 片段:UNP residues 27-345
链 L 346–519(174 aa) 片段:UNP residues 346-519
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;28% w/v PEG400, 200 mM calcium chloride, 100 mM HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 4.10 Å R-free 0.334
4FQR Crystal structure of broadly neutralizing antibody C05 bound to H3 influenza hemagglutinin 提交 2012-06-25 Assembly 3 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 M 27–345(319 aa) 片段:UNP residues 27-345
链 N 346–519(174 aa) 片段:UNP residues 346-519
链 O 27–345(319 aa) 片段:UNP residues 27-345
链 P 346–519(174 aa) 片段:UNP residues 346-519
链 Q 27–345(319 aa) 片段:UNP residues 27-345
链 R 346–519(174 aa) 片段:UNP residues 346-519
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;28% w/v PEG400, 200 mM calcium chloride, 100 mM HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 4.10 Å R-free 0.334
4FQR Crystal structure of broadly neutralizing antibody C05 bound to H3 influenza hemagglutinin 提交 2012-06-25 Assembly 4 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 S 27–345(319 aa) 片段:UNP residues 27-345
链 T 346–519(174 aa) 片段:UNP residues 346-519
链 U 27–345(319 aa) 片段:UNP residues 27-345
链 V 346–519(174 aa) 片段:UNP residues 346-519
链 W 27–345(319 aa) 片段:UNP residues 27-345
链 X 346–519(174 aa) 片段:UNP residues 346-519
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;28% w/v PEG400, 200 mM calcium chloride, 100 mM HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 4.10 Å R-free 0.334
4FQY Crystal structure of broadly neutralizing antibody CR9114 bound to H3 influenza hemagglutinin 提交 2012-06-25 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 27–345(319 aa) 片段:UNP residues 27-345
链 B 346–519(174 aa) 片段:UNP residues 346-519
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;200 mM zinc acetate, 14% PEG1000, 100 mM sodium acetate, pH 4.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 5.25 Å R-free 0.374
4NM8 Crystal structure of broadly neutralizing antibody CR8043 bound to H3 influenza hemagglutinin 提交 2013-11-14 Assembly 1 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–521(176 aa)
链 C 27–345(319 aa)
链 D 346–521(176 aa)
链 E 27–345(319 aa)
链 F 346–521(176 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;2.2 M ammonium sulfate, 0.1 M sodium acetate pH 5.5, 3% PEG 400, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 4.00 Å R-free 0.292
4UBD Crystal structure of a neutralizing human monoclonal antibody with 1968 H3 HA 提交 2014-08-12 Assembly 1 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 25–344(320 aa)
链 B 346–520(175 aa)
链 E 25–344(320 aa)
链 F 346–520(175 aa)
链 I 25–344(320 aa)
链 J 346–520(175 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;20% PEG 3000, 100mM Na Citrate
分辨率 3.50 Å R-free 0.258
4UBD Crystal structure of a neutralizing human monoclonal antibody with 1968 H3 HA 提交 2014-08-12 Assembly 2 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 M 25–344(320 aa)
链 N 346–520(175 aa)
链 Q 25–344(320 aa)
链 R 346–520(175 aa)
链 U 25–344(320 aa)
链 V 346–520(175 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;20% PEG 3000, 100mM Na Citrate
分辨率 3.50 Å R-free 0.258
4WE4 The crystal structure of hemagglutinin from 1968 H3N2 influenza virus 提交 2014-09-09 Assembly 1 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–345(321 aa) 片段:unp residues 25-345
链 B 346–517(172 aa) 片段:unp residues 346-517
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 PEG DI(HYDROXYETHYL)ETHER × 21 PE5 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL × 3 X-RAY DIFFRACTION
X-ray结晶条件 MICROBATCH;pH 7.9;293 K;0.1M Tris-HCl, 25% PEG1000
分辨率 2.35 Å R-free 0.236
4ZCJ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin HA1 Cys30, HA2 Cys47 mutant 提交 2015-04-16 Assembly 1 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa) 片段:HA1 chain (UNP residues 27-345)
链 B 346–521(176 aa) 片段:HA2 chain (UNP residues 346-521)
链 C 27–345(319 aa) 片段:HA1 chain (UNP residues 27-345)
链 D 346–521(176 aa) 片段:HA2 chain (UNP residues 346-521)
链 E 27–345(319 aa) 片段:HA1 chain (UNP residues 27-345)
链 F 346–521(176 aa) 片段:HA2 chain (UNP residues 346-521)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;8% PEG 8000, 0.1 M HEPES pH 7
分辨率 3.00 Å R-free 0.275
5K9K Crystal structure of multidonor HV6-1-class broadly neutralizing Influenza A antibody 56.a.09 in complex with Hemagglutinin Hong Kong 1968. 提交 2016-05-31 Assembly 1 其他组合 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 I 17–519(503 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.28M ammonium citrate, pH 8.5, and 12.5% (w/v) PEG-8000
分辨率 2.97 Å R-free 0.265
5K9K Crystal structure of multidonor HV6-1-class broadly neutralizing Influenza A antibody 56.a.09 in complex with Hemagglutinin Hong Kong 1968. 提交 2016-05-31 Assembly 2 其他组合 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 F 17–519(503 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.28M ammonium citrate, pH 8.5, and 12.5% (w/v) PEG-8000
分辨率 2.97 Å R-free 0.265
5K9Q Crystal structure of multidonor HV1-18-class broadly neutralizing Influenza A antibody 16.a.26 in complex with A/Hong Kong/1-4-MA21-1/1968 (H3N2) Hemagglutinin 提交 2016-06-01 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 24–343(320 aa)
链 B 348–517(170 aa)
链 C 24–343(320 aa)
链 D 348–517(170 aa)
链 E 24–343(320 aa)
链 F 348–517(170 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.01M L-cysteine, 0.09M sodium cacodylate, pH 6.5, 0.18M magnesium acetate, and 7.9% (w/v) PEG-8000
分辨率 2.50 Å R-free 0.218
5K9Q Crystal structure of multidonor HV1-18-class broadly neutralizing Influenza A antibody 16.a.26 in complex with A/Hong Kong/1-4-MA21-1/1968 (H3N2) Hemagglutinin 提交 2016-06-01 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 M 24–343(320 aa)
链 N 348–517(170 aa)
链 O 24–343(320 aa)
链 P 348–517(170 aa)
链 Q 24–343(320 aa)
链 R 348–517(170 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.01M L-cysteine, 0.09M sodium cacodylate, pH 6.5, 0.18M magnesium acetate, and 7.9% (w/v) PEG-8000
分辨率 2.50 Å R-free 0.218
5KAN Crystal structure of multidonor HV1-18-class broadly neutralizing Influenza A antibody 16.g.07 in complex with A/Hong Kong/1-4-MA21-1/1968 (H3N2) Hemagglutinin 提交 2016-06-01 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 24–342(319 aa)
链 B 349–521(173 aa)
链 C 24–342(319 aa)
链 D 349–521(173 aa)
链 E 24–342(319 aa)
链 F 349–521(173 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;0.010M Tris(2-carboxyethyl)phosphine HCl (TCEP) , 0.09 M 2-(N-morpholino)ethanesulfonic acid (MES), pH 6.0, 12% (w/v) PEG-6000
分辨率 2.79 Å R-free 0.243
5KUY Influenza hemagglutinin H3 A/Hong Kong/1/1968 in complex with designed inhibitor protein HSB.2A 提交 2016-07-13 Assembly 1 其他组合 异源复合物;蛋白 × 9 PDB 声明:nonameric(9) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–521(176 aa)
链 C 27–345(319 aa)
链 D 346–521(176 aa)
链 E 27–345(319 aa)
链 F 346–521(176 aa)
突变:R452G 突变:R452G 突变:R452G NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;10% PEG 6000, 100 mM MES pH 6.0
分辨率 2.60 Å R-free 0.204
5T6N Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin in complex with the antiviral drug arbidol 提交 2016-09-01 Assembly 1 其他组合 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 C 27–345(319 aa)
链 E 27–345(319 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 75U ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indole-3-carboxylate × 3 SO4 SULFATE ION × 4 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;2.0 M ammonium sulfate, 100 mM sodium cacodylate, 200 mM sodium chloride
分辨率 2.54 Å R-free 0.220
5THF Crystal structure of H3 hemagglutinin with insertion of two amino acids in the 150-loop from the A/Hong Kong/1/1968 (H3N2) influenza virus 提交 2016-09-29 Assembly 1 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–521(176 aa)
链 C 27–345(319 aa)
链 D 346–521(176 aa)
链 E 27–345(319 aa)
链 F 346–521(176 aa)
突变:Insertion 突变:R468G 突变:Insertion 突变:R468G 突变:Insertion 突变:R468G NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;20% (w/v) PEG 3500, 0.2M Na2HPO4 pH 9.1
分辨率 2.59 Å R-free 0.239
5UMN Crystal structure of C05 VPGSGW mutant bound to H3 influenza hemagglutinin, HA1 subunit 提交 2017-01-27 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 59–325(267 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 1PE PENTAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.1 M sodium citrate pH 5.5 and 9% PEG 8000
分辨率 1.97 Å R-free 0.208
5UMN Crystal structure of C05 VPGSGW mutant bound to H3 influenza hemagglutinin, HA1 subunit 提交 2017-01-27 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 B 59–325(267 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 1PE PENTAETHYLENE GLYCOL × 3 NA SODIUM ION × 1 FLC CITRATE ANION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.1 M sodium citrate pH 5.5 and 9% PEG 8000
分辨率 1.97 Å R-free 0.208
5VTQ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant in complex with 3'-SLN 提交 2017-05-17 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
突变:G225L/L226S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.95 Å R-free 0.228
5VTQ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant in complex with 3'-SLN 提交 2017-05-17 Assembly 2 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 27–345(319 aa)
链 D 346–519(174 aa)
突变:G225L/L226S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.95 Å R-free 0.228
5VTQ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant in complex with 3'-SLN 提交 2017-05-17 Assembly 3 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225L/L226S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.95 Å R-free 0.228
5VTQ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant in complex with 3'-SLN 提交 2017-05-17 Assembly 4 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
链 C 27–345(319 aa)
链 D 346–519(174 aa)
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225L/L226S 突变:G225L/L226S 突变:G225L/L226S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.95 Å R-free 0.228
5VTR Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
突变:G225L/L226S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.50 Å R-free 0.213
5VTR Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 2 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 27–345(319 aa)
链 D 346–519(174 aa)
突变:G225L/L226S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SIA N-acetyl-alpha-neuraminic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.50 Å R-free 0.213
5VTR Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 3 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225L/L226S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SIA N-acetyl-alpha-neuraminic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.50 Å R-free 0.213
5VTR Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 4 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
链 C 27–345(319 aa)
链 D 346–519(174 aa)
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225L/L226S 突变:G225L/L226S 突变:G225L/L226S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 SIA N-acetyl-alpha-neuraminic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.50 Å R-free 0.213
5VTU Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant apo form 提交 2017-05-18 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M potassium nitrate and 20% PEG 3350
分辨率 2.45 Å R-free 0.220
5VTU Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant apo form 提交 2017-05-18 Assembly 2 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 27–345(319 aa)
链 D 346–519(174 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M potassium nitrate and 20% PEG 3350
分辨率 2.45 Å R-free 0.220
5VTU Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant apo form 提交 2017-05-18 Assembly 3 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 27–345(319 aa)
链 F 346–519(174 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M potassium nitrate and 20% PEG 3350
分辨率 2.45 Å R-free 0.220
5VTU Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225L/L226S mutant apo form 提交 2017-05-18 Assembly 4 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
链 C 27–345(319 aa)
链 D 346–519(174 aa)
链 E 27–345(319 aa)
链 F 346–519(174 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M potassium nitrate and 20% PEG 3350
分辨率 2.45 Å R-free 0.220
5VTV Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant in complex with 3'-SLN 提交 2017-05-18 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.212
5VTV Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant in complex with 3'-SLN 提交 2017-05-18 Assembly 2 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 27–345(319 aa)
链 D 346–519(174 aa)
突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.212
5VTV Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant in complex with 3'-SLN 提交 2017-05-18 Assembly 3 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.212
5VTV Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant in complex with 3'-SLN 提交 2017-05-18 Assembly 4 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
链 C 27–345(319 aa)
链 D 346–519(174 aa)
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225M/L226T/S228A 突变:G225M/L226T/S228A 突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.212
5VTW Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SIA N-acetyl-alpha-neuraminic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.35 Å R-free 0.213
5VTW Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 2 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 27–345(319 aa)
链 D 346–519(174 aa)
突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.35 Å R-free 0.213
5VTW Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 3 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.35 Å R-free 0.213
5VTW Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 4 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
链 C 27–345(319 aa)
链 D 346–519(174 aa)
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225M/L226T/S228A 突变:G225M/L226T/S228A 突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 SIA N-acetyl-alpha-neuraminic acid × 1 TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.35 Å R-free 0.213
5VTX Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant apo form 提交 2017-05-18 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.65 Å R-free 0.217
5VTX Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant apo form 提交 2017-05-18 Assembly 2 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 27–345(319 aa)
链 D 346–519(174 aa)
突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.65 Å R-free 0.217
5VTX Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant apo form 提交 2017-05-18 Assembly 3 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.65 Å R-free 0.217
5VTX Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225M/L226T/S228A mutant apo form 提交 2017-05-18 Assembly 4 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
链 C 27–345(319 aa)
链 D 346–519(174 aa)
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225M/L226T/S228A 突变:G225M/L226T/S228A 突变:G225M/L226T/S228A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.65 Å R-free 0.217
5VTY Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant in complex with 3'-SLN 提交 2017-05-18 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
突变:G225Q/L226A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.36 Å R-free 0.210
5VTY Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant in complex with 3'-SLN 提交 2017-05-18 Assembly 2 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 27–345(319 aa)
链 D 346–519(174 aa)
突变:G225Q/L226A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.36 Å R-free 0.210
5VTY Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant in complex with 3'-SLN 提交 2017-05-18 Assembly 3 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225Q/L226A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.36 Å R-free 0.210
5VTY Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant in complex with 3'-SLN 提交 2017-05-18 Assembly 4 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
链 C 27–345(319 aa)
链 D 346–519(174 aa)
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225Q/L226A 突变:G225Q/L226A 突变:G225Q/L226A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.36 Å R-free 0.210
5VTZ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant apo form 提交 2017-05-18 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
突变:G225Q/L226A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.15 Å R-free 0.199
5VTZ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant apo form 提交 2017-05-18 Assembly 2 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 27–345(319 aa)
链 D 346–519(174 aa)
突变:G225Q/L226A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.15 Å R-free 0.199
5VTZ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant apo form 提交 2017-05-18 Assembly 3 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225Q/L226A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.15 Å R-free 0.199
5VTZ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant apo form 提交 2017-05-18 Assembly 4 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
链 C 27–345(319 aa)
链 D 346–519(174 aa)
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:G225Q/L226A 突变:G225Q/L226A 突变:G225Q/L226A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.15 Å R-free 0.199
5VU4 Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.208
5VU4 Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 2 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 27–345(319 aa)
链 D 346–519(174 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SIA N-acetyl-alpha-neuraminic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.208
5VU4 Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 3 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 27–345(319 aa)
链 F 346–519(174 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 SIA N-acetyl-alpha-neuraminic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.208
5VU4 Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin G225Q/L226A mutant in complex with 6'-SLN 提交 2017-05-18 Assembly 4 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
链 C 27–345(319 aa)
链 D 346–519(174 aa)
链 E 27–345(319 aa)
链 F 346–519(174 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 SIA N-acetyl-alpha-neuraminic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.208
6BKM Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin E190D mutant apo form 提交 2017-11-09 Assembly 1 其他组合 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 27–345(319 aa)
链 C 27–345(319 aa)
链 E 27–345(319 aa)
突变:E190D 突变:E190D 突变:E190D NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 6% PEG 8000, and 39% 2-methyl-2,4-pentanediol
分辨率 2.20 Å R-free 0.209
6BKM Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin E190D mutant apo form 提交 2017-11-09 Assembly 3 其他组合 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 C 27–345(319 aa)
链 E 27–345(319 aa)
突变:E190D 突变:E190D 突变:E190D NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 6% PEG 8000, and 39% 2-methyl-2,4-pentanediol
分辨率 2.20 Å R-free 0.209
6BKQ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin E190D mutant in complex with 6'-SLN 提交 2017-11-09 Assembly 1 其他组合 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 27–345(319 aa)
链 C 27–345(319 aa)
链 E 27–345(319 aa)
突变:E190D 突变:E190D 突变:E190D NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 6% PEG 8000, and 39% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.208
6BKQ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin E190D mutant in complex with 6'-SLN 提交 2017-11-09 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 B 346–519(174 aa)
链 D 346–519(174 aa)
链 F 346–519(174 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 6% PEG 8000, and 39% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.208
6BKQ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin E190D mutant in complex with 6'-SLN 提交 2017-11-09 Assembly 3 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–519(174 aa)
链 C 27–345(319 aa)
链 D 346–519(174 aa)
链 E 27–345(319 aa)
链 F 346–519(174 aa)
突变:E190D 突变:E190D 突变:E190D NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 6% PEG 8000, and 39% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.208
6CEX Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin in complex with small molecule N-Cyclohexyltaurine 提交 2018-02-12 Assembly 1 其他组合 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa)
链 C 27–345(319 aa)
链 E 27–345(319 aa)
未记录 NHE 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 SO4 SULFATE ION × 6 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;2.0 M ammonium sulfate, 100 mM sodium cacodylate, 200 mM sodium chloride, pH 6.5, 20 degree
分辨率 2.57 Å R-free 0.204
6D0U Crystal structure of C05 V110P/A117E mutant bound to H3 influenza hemagglutinin, HA1 subunit 提交 2018-04-11 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 59–325(267 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.1 M sodium citrate pH 5.5 and 20% PEG 3000
分辨率 3.25 Å R-free 0.268
6D0U Crystal structure of C05 V110P/A117E mutant bound to H3 influenza hemagglutinin, HA1 subunit 提交 2018-04-11 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 B 59–325(267 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.1 M sodium citrate pH 5.5 and 20% PEG 3000
分辨率 3.25 Å R-free 0.268
6D0U Crystal structure of C05 V110P/A117E mutant bound to H3 influenza hemagglutinin, HA1 subunit 提交 2018-04-11 Assembly 3 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 J 59–325(267 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.1 M sodium citrate pH 5.5 and 20% PEG 3000
分辨率 3.25 Å R-free 0.268
6D0U Crystal structure of C05 V110P/A117E mutant bound to H3 influenza hemagglutinin, HA1 subunit 提交 2018-04-11 Assembly 4 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 G 59–325(267 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.1 M sodium citrate pH 5.5 and 20% PEG 3000
分辨率 3.25 Å R-free 0.268
6NHP Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin HA2 I45T mutant 提交 2018-12-23 Assembly 1 其他组合 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 346–521(176 aa) 片段:residues 346-521
链 D 346–521(176 aa) 片段:residues 346-521
链 F 346–521(176 aa) 片段:residues 346-521
突变:I45T 突变:I45T 突变:I45T NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.25 Å R-free 0.208
6NHQ Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin HA2 I45M mutant 提交 2018-12-23 Assembly 1 其他组合 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa) 片段:residues 27-345
链 B 346–521(176 aa) 片段:residues 346-521
链 C 27–345(319 aa) 片段:residues 27-345
链 D 346–521(176 aa) 片段:residues 346-521
链 E 27–345(319 aa) 片段:residues 27-345
链 F 346–521(176 aa) 片段:residues 346-521
突变:I45M 突变:I45M 突变:I45M NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.50 Å R-free 0.219
6NHR Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin HA2 I45F mutant 提交 2018-12-23 Assembly 1 其他组合 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 346–521(176 aa) 片段:residues 346-521
链 D 346–521(176 aa) 片段:residues 346-521
链 F 346–521(176 aa) 片段:residues 346-521
突变:I45F 突变:I45F 突变:I45F NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 38% 2-methyl-2,4-pentanediol
分辨率 2.10 Å R-free 0.216
6NZ7 Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968 提交 2019-02-13 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 24–342(319 aa) 片段:residues 24-342
链 B 349–521(173 aa) 片段:residues 349-521
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;300 K;10 % PEG8000 (w/v), 100 mM Tris/Cl, pH 8.5 and 7.5 % 1,6-hexanediol (w/v)
分辨率 2.95 Å R-free 0.267
6NZ7 Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968 提交 2019-02-13 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 E 24–342(319 aa) 片段:residues 24-342
链 F 349–521(173 aa) 片段:residues 349-521
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;300 K;10 % PEG8000 (w/v), 100 mM Tris/Cl, pH 8.5 and 7.5 % 1,6-hexanediol (w/v)
分辨率 2.95 Å R-free 0.267
6OCB Crystal structure of FluA-20 Fab in complex with the head domain of H3 (A/Hong Kong/1/1968) 提交 2019-03-22 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 59–325(267 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277.15 K;0.1 M Tris-HCl pH 8.5 0.2 M lithium sulfate 40% (v/v) PEG400
分辨率 2.10 Å R-free 0.239
6TZB Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin in complex with 6'-SLNLN 提交 2019-08-12 Assembly 1 其他组合 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 27–345(319 aa) 片段:residues 27-345
链 C 27–345(319 aa) 片段:residues 27-345
链 E 27–345(319 aa) 片段:residues 27-345
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 6% PEG 8000, and 39% 2-methyl-2,4-pentanediol
分辨率 2.24 Å R-free 0.207
6WXB Cryo-EM Structure of Influenza Hemagglutinin (HA) Trimer Vitrified Using Back-it-up 提交 2020-05-10 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 17–527(511 aa)
链 B 17–527(511 aa)
链 C 17–527(511 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 BMA beta-D-mannopyranose × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4
cryo-EM玻璃化条件 冷冻剂 ETHANE-PROPANE;Back-it-up (ultrasonic specimen application and through-grid wicking in a high-speed specimen preparation device) was used
分辨率 2.90 Å
7K37 Structure of full-length influenza HA with a head-binding antibody at pH 7.8 提交 2020-09-10 Assembly 1 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 1–345(345 aa)
链 C 1–345(345 aa)
链 E 1–345(345 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.80 Å
7K39 Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation A, neutral pH-like 提交 2020-09-10 Assembly 1 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 1–345(345 aa)
链 C 1–345(345 aa)
链 E 1–345(345 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 5.2
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.00 Å
7K3A Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation B, fusion peptide release 提交 2020-09-10 Assembly 1 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 1–345(345 aa)
链 C 1–345(345 aa)
链 E 1–345(345 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 5.2
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.20 Å
7K3B Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation C, central helices splay 提交 2020-09-10 Assembly 1 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 1–345(345 aa)
链 C 1–345(345 aa)
链 E 1–345(345 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 5.2
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.40 Å
7QA4 Crystal structure of stabilized H3N2 A/Hong Kong/1/1968 Hemagglutinin at 2.2 Angstrom 提交 2021-11-16 Assembly 1 其他组合 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 17–521(505 aa) 片段:Hemagglutinin
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 NO3 NITRATE ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;20.00 %w/v PEG 3350, 0.2 M LiNO3
分辨率 2.19 Å R-free 0.251
7RDH Crystal structure of the de novo designed binding protein H3mb in complex with the 1968 influenza A virus hemagglutinin 提交 2021-07-09 Assembly 1 其他组合 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 27–345(319 aa)
链 B 346–521(176 aa)
链 C 27–345(319 aa)
链 D 346–521(176 aa)
链 E 27–345(319 aa)
链 F 346–521(176 aa)
突变:R123G 突变:R123G 突变:R123G NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M sodium thiocyanate and 20% (w/v) polyethylene glycol 3350 as a precipitant
分辨率 2.75 Å R-free 0.289
7VDF 2.56 A structure of influenza hemagglutinin (HA) trimer 提交 2021-09-06 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 17–527(511 aa)
链 B 17–527(511 aa)
链 C 17–527(511 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 BMA beta-D-mannopyranose × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.56 Å
7X6L Cryo-EM structure of H3 hemagglutinin from A/HongKong/01/1968 in complex with a neutralizing antibody 28-12 提交 2022-03-07 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 17–345(329 aa)
链 C 17–345(329 aa)
链 D 17–345(329 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.70 Å
8PK3 CryoEM reconstruction of hemagglutinin HK68 of Influenza A virus bound to an Affimer reagent 提交 2023-06-24 Assembly 1 其他组合 异源复合物;蛋白 × 9 PDB 声明:nonameric(9) 与蛋白数一致
链 A 27–344(318 aa)
链 B 27–344(318 aa)
链 C 27–344(318 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.40 Å
9CXT Hemagglutinin A/Hong Kong/1/68 produced in GnTI- cells 提交 2024-07-31 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 17–344(328 aa)
链 B 345–524(180 aa)
链 C 17–344(328 aa)
链 D 345–524(180 aa)
链 E 17–344(328 aa)
链 F 345–524(180 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;TBS
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.40 Å
9CXU Endo H-treated hemagglutinin A/Hong Kong/1/68 提交 2024-07-31 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 17–344(328 aa)
链 B 345–524(180 aa)
链 C 17–344(328 aa)
链 D 345–524(180 aa)
链 E 17–344(328 aa)
链 F 345–524(180 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;TBS
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.30 Å